Wakefield,  MA 
United States
  • Booth: 558

Bioctogen Boston Corporation is a Biotech CRO offering custom gene targeting services, featuring CRISPR-based EGE® technology, which increases large fragment knockin efficiency by 10-20-fold. Biocytogen also offers Immuno-Oncology drug validation services that rely on independently-developed humanized immune-checkpoint mouse models (e.g. B-hPD-1 mice) and immune-deficient, human immune system-reconstituted mice (B-NDG model).

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".

For Technical Support with this webpage, please contact support.